210 related articles for article (PubMed ID: 17185722)
1. Getting new drugs to market: how individuals could do this without leaving their desks.
Collier J
BMJ; 2006 Dec; 333(7582):1315-7. PubMed ID: 17185722
[No Abstract] [Full Text] [Related]
2. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
3. Market watch: pricing strategies for emerging markets.
Lineberry N; Snyder E; Gunda S
Nat Rev Drug Discov; 2011 Aug; 10(8):567. PubMed ID: 21804586
[No Abstract] [Full Text] [Related]
4. Can China bring its own pipeline to the market?
Louët S
Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
[No Abstract] [Full Text] [Related]
5. [Why do good drugs disappear?].
Brezis M; Tomer R; Klang S; Hammerman A
Harefuah; 2010 Oct; 149(10):652-5, 683. PubMed ID: 21568061
[TBL] [Abstract][Full Text] [Related]
6. Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
Jiang S; Chen Z; Wu T; Wang H
J Glob Health; 2020 Jun; 10(1):010314. PubMed ID: 32566150
[No Abstract] [Full Text] [Related]
7. [Drug shortage--cause and prevention].
Madsen S; Claesson U; Wesenberg GR; Endresen M; Walter AB
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2154-5. PubMed ID: 23076482
[No Abstract] [Full Text] [Related]
8. More drugs, less protection.
Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
[No Abstract] [Full Text] [Related]
9. Pharmaceutical supply chain in China: current issues and implications for health system reform.
Yu X; Li C; Shi Y; Yu M
Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
[TBL] [Abstract][Full Text] [Related]
10. What can Johnson & Johnson do to remain a giant in the health care industry?
Carter T
J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical sector in transition--a cross sectional study in Vietnam.
Falkenberg T; Nguyen TB; Larsson M; Nguyen TD; Tomson G
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):590-7. PubMed ID: 11289028
[TBL] [Abstract][Full Text] [Related]
12. [On misery coast. Episode 1: the market of vital drugs].
Chneiweiss H
Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
[No Abstract] [Full Text] [Related]
13. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
14. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Buckely M
Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
[No Abstract] [Full Text] [Related]
15. [Scientific concept of providing Russian population with drugs].
Nechaev EA
Vestn Ross Akad Med Nauk; 1994; (7):5-10. PubMed ID: 7524855
[No Abstract] [Full Text] [Related]
16. Priced out of the UK market.
Moran N
Nat Biotechnol; 2008 Feb; 26(2):151-4. PubMed ID: 18259163
[No Abstract] [Full Text] [Related]
17. EU agrees deal on cheaper drugs for developing world.
Watson R
BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716
[No Abstract] [Full Text] [Related]
18. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
Germani C; Montanari L; Petraroja A
Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
[No Abstract] [Full Text] [Related]
19. Drug shortage crisis affects patients and nurses.
Carter D
Am J Nurs; 2011 Nov; 111(11):14. PubMed ID: 22030911
[No Abstract] [Full Text] [Related]
20. Access to medicines report cards.
Mullard A
Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
